Ferroptosis and Charcot-Marie-Tooth Disease 1A: Emerging Evidence for a Pathogenic Association

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Charcot-Marie-Tooth disease (CMT) is a prevalent hereditary peripheral neuropathy.
• CMT1A, the most common subtype, results from PMP22 gene duplication, impacting Schwann cell myelin.
• Oxidative stress and lipid peroxidation are implicated in CMT1A neurodegeneration.

Purpose of the Study:

• To establish the pathogenic link between Charcot-Marie-Tooth disease type 1A (CMT1A) and ferroptosis.
• To investigate the role of ferroptosis in CMT1A pathogenesis at the cellular level.

Main Methods:

• Assessed susceptibility of human CMT1A fibroblasts to the ferroptosis inducer RSL3.
• Measured ferroptosis markers (lipid peroxides, GPX4) in CMT1A fibroblasts.
• Performed transcriptomic analysis of human induced pluripotent stem cell (iPSC)-derived Schwann cells from CMT1A patients.

Main Results:

• CMT1A fibroblasts exhibited increased sensitivity to RSL3 and elevated ferroptosis markers.
• Human iPSC-derived Schwann cells from CMT1A patients showed heightened ferroptosis activation and cellular stress.
• Evidence suggests lipid peroxide accumulation and impaired antioxidant defenses in CMT1A.

Conclusions:

• Ferroptosis is identified as a significant contributor to Charcot-Marie-Tooth disease type 1A pathology.
• Chronic, sublethal ferroptotic stress in Schwann cells may lead to age-dependent neurodegeneration in CMT1A.
• Targeting ferroptosis presents a potential novel therapeutic strategy for CMT1A.